Endo Pharma to withdraw application for new opioid painkiller formulation

Shares rose as much as 4% on the news.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.